SecBot SecBot
S-1/A ·Filed Feb 24, 2026

BWIV

Blue Water Acquisition Corp. IV
NEUTRAL
Impact 3/10
Horizonmonths Processed8mo ago SEC0001493152-26-007866
IPO registration amendment
Actionable Insight • Neutral

Monitor for potential business combination targets in biotech/healthcare sectors within the 24-month window. Watch for any extensions to this deadline, which would require shareholder approval and offer redemption rights.

DirectionNeutral
Confidencehigh
Horizonmonths

Executive Summary

Blue Water Acquisition Corp. IV (BWIV) is a blank check company formed to complete a business combination with a target in biotechnology, healthcare, or technology sectors. The company raised $125 million through an IPO of 12.5 million units at $10 each, with proceeds held in trust. The sponsor acquired founder shares at a nominal price, creating significant dilution for public shareholders. The company has 24 months to complete a business combination or face liquidation.

Key Financial Metrics

Price Range
$10.00 per unit

Key Facts

  • BWIV is a SPAC formed to acquire a business in biotechnology, healthcare, or technology sectors
  • Raised $125 million through IPO of 12.5 million units at $10 per unit
  • Proceeds held in trust account, with $125 million to be used for business combination
  • Sponsor acquired 4.79 million founder shares for $25,000, creating significant dilution for public shareholders
  • Company has 24 months to complete business combination or liquidate
  • Public shareholders can redeem shares for approximately $10 per share if no business combination is completed
  • Management team has experience with previous SPACs but resigned from prior company in November 2025

Financial Impact

Raised $125 million in gross proceeds, with $125 million held in trust for business combination

proceedsdilutiontrust account balance

Risk Factors

  • Failure to complete business combination within 24 months would trigger liquidation
  • Significant dilution for public shareholders due to founder shares purchased at nominal price
  • Management conflicts of interest as sponsor stands to profit substantially even if public shareholders lose money

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 2 SEC documents filed with EDGAR.

DocumentAccession Number
S-1/A Filing (Primary)0001493152-26-007866
Exhibit: ex1-1.htm0001493152-26-007866
6 reports for BWIV
Performance horizon
Filters
Rows
Reports for BWIV — sortable, filterable
TypeNow
May 6, 2026
24w ago
8-K
NEUTRAL ★ 2/10
$10.08 $10.04▼ −0.40%▼ −3.18%$9.98 (−0.99%)
Apr 28, 2026
26w ago
8-K / 425
NEUTRAL ★ 5/10
$10.09 $10.10▲ +0.10%▼ −5.95%$9.98 (−1.09%)
Mar 20, 2026
31w ago
424B4
NEUTRAL ★ 5/10
—awaiting T+20——
Mar 20, 2026
31w ago
EFFECT
NEUTRAL ★ 4/10
—awaiting T+20——
Mar 11, 2026
32w ago
S-1/A
NEUTRAL ★ 5/10
—awaiting T+20——
Feb 24, 2026
35w ago
S-1/A
NEUTRAL ★ 3/10
—awaiting T+20——
Showing 6 of 6

US Market Status

Market Closed — Opens Thu (12h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 24, 2026